Skip to main content

Assistance Fund: Duchenne Muscular Dystrophy

The Assistance Fund

OpenVerified·Apr 24, 2026

The Assistance Fund: Duchenne Muscular Dystrophy provides financial support for U.S. and Puerto Rico residents to cover copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved Duchenne Muscular Dystrophy treatments. Eligibility is needs-based and requires patients to be commercially insured, Medicare, or Medicaid recipients.

Covers
financial assistance
Enrollment cycle
as_funded

Eligibility

Eligibility requires US or Puerto Rico residency and coverage by commercial insurance, Medicare, or Medicaid for Duchenne Muscular Dystrophy treatments. The program is needs-based and requires verification of demographic, insurance, and financial information.

Apply

Application goes directly to The Assistance Fund. RxCopays does not receive compensation.

Go to application →

Status source

Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: